جست‌وجوی استاد و پژوهشگر

Liz Coulthardمشاهده پروفایل

استاد

• Cognitive Neurology
• Dementia Research
• Alzheimer's Disease
• +۴ مورد دیگر

Professor Liz Coulthard holds the position of Professor of Cognitive Neurology at the University of Bristol's Bristol Medical School (THS). She specializes in clinical neurology with a focus on dementia and cognitive impairments. Her research integrates clinical practice with epidemiological and neuroimaging approaches. Education: BA (Oxford University), MBBS (University College London), MRCP, PhD (University College London). Research interests center on Alzheimer's disease mechanisms, sleep disturbances in neurodegenerative disorders, and early detection strategies. She leads studies on biomarkers like Fastball neurocognitive assessment and investigates interventions such as liraglutide for Alzheimer's treatment. Her work includes large-scale cohort studies like SleepQuest and the RESTED-AD observational study. Key innovations include remote sleep monitoring protocols and interdisciplinary collaborations with engineers for soft robotics solutions in dementia care. She has contributed to clinical trials evaluating drugs like losartan and liraglutide for neuroprotective effects.

Jed Mortonمشاهده پروفایل

پژوهشگر ارشد

• Epidemiology
• Epidemiological Modelling
• Health Economic Analysis
• +۳ مورد دیگر

Jed Morton is a Research Fellow at the Faculty of Pharmacy and Pharmaceutical Sciences at Monash University, affiliated with the Centre for Medicine Use and Safety . His work focuses on epidemiology, epidemiological modelling, and health economic analysis of diabetes, cardiovascular disease, and kidney disease. He holds a PhD in Epidemiology (Monash University, 2022) and a BSc (Hons) in Science from the University of Melbourne (2018). Dr. Morton contributes to the UN Sustainable Development Goals through research addressing health inequities and chronic disease burden. He holds an external position as part of the Cardiovascular Learning Health Network Data group at Safer Care Victoria (SCV) since October 2022, emphasizing collaboration in healthcare improvement. His research spans topics like diabetes-related end-stage kidney disease projections, socioeconomic disparities in medication access, and cardiovascular disease prevention economics. Notable collaborations include multinational studies on diabetes epidemiology and outcomes. Press coverage highlights his work on cost-effective diabetes drugs and cardiovascular disease prevention strategies. Publications reflect expertise in health economics, registry-based cohort analyses, and disease burden modelling. His work bridges clinical data and policy implications, with a focus on improving healthcare equity and outcomes in chronic disease management.

• Infectious Diseases
• HIV-Tuberculosis Co-infection
• Immune Mechanisms
• +۳ مورد دیگر

Professor Robert Wilkinson is a Professor in Infectious Diseases at Imperial College London's Faculty of Medicine (since 2007), with concurrent roles as Principal Group Leader at the Francis Crick Institute and Honorary Professor at the University of Cape Town. His research focuses on HIV-TB co-infection mechanisms, immune reconstitution inflammatory syndrome (IRIS), and tuberculosis diagnostics/prevention. Affiliations include the Institute of Infection, Vaccine Research Network, and Immuno-Pathology Network. Education: MA (Cambridge), BM BCh (Oxford), PhD (Royal Postgraduate Medical School), and multiple specialist certifications including FRCP and Fellowship of the Academy of Medical Sciences. Research emphasizes translational studies in TB pathogenesis, biomarker discovery (e.g., transcriptomic signatures), and clinical trials evaluating interventions like vitamin D supplementation and MVA85A vaccines. Key achievements include landmark studies on IPT efficacy in HIV/TB co-infected populations, identification of IL-10/IL-22 roles in TB-IRIS, and discovery of blood transcriptomic profiles predictive of TB progression. His work has influenced WHO policy and advanced understanding of TB latency, pericarditis pathogenesis, and immune modulation.

Harry P.W. Kozakewichمشاهده پروفایل

استاد

• Vascular Malformations
• Pediatric Pathology
• Oncologic Pathology
• +۲ مورد دیگر

Harry P.W. Kozakewich, MD, is Professor of Pathology at Harvard Medical School and practices at Boston Children's Hospital within the Department of Pathology. He specializes in pediatric pathology with a focus on vascular malformations, hemangiomas, and oncologic pathology. His clinical work and research center on characterizing vascular anomalies and developing diagnostic approaches for pediatric tumors. Education: Medical School: University of Saskatchewan College of Medicine (1967) Internship: Saint Boniface Hospital (1968) Residencies: Diagnostic Radiology (New York Hospital-Cornell Medical Center, 1971), Pathology (Boston City Hospital, 1972, 1976), Anatomic Pathology and Diagnostic Radiology (Boston Children's Hospital, 1975) Fellowship: Oncologic Pathology, Sloan-Kettering Memorial Hospital (1978) Research Focus: Dr. Kozakewich's work explores the molecular mechanisms underlying vascular anomalies, including hemangiomas and lymphatic malformations. His investigations span genetic drivers (e.g., GNAQ/GNA11 mutations), endothelial cell biology, and preclinical models to identify therapeutic targets. His recent studies emphasize mevalonate pathway dysregulation in infantile hemangiomas and mutation-specific pathology in capillary malformations. Publication Trends: His recent articles (2020-2025) demonstrate a focus on genetic characterization of vascular anomalies, immunohistochemical markers for diagnosis, and mechanistic insights from animal models. Key themes include somatic mutations in vascular tumors, lymphatic malformation pathology, and clinical-pathological correlations for rare pediatric conditions. Certifications: American Board of Pathology (Anatomic Cytopathology) American Board of Radiology (Diagnostic Radiology)

Raymond Chungمشاهده پروفایل

استاد

• Hepatology
• Virology
• Immunology
• +۵ مورد دیگر

Dr. Raymond Chung is a Professor of Medicine at Harvard Medical School and serves as the Director of Hepatology and Vice Chief of the Gastrointestinal Division at Massachusetts General Hospital. His work focuses on hepatitis virus pathogenesis and antiviral strategies. NIH-funded research on HCV persistence mechanisms Leader of the NIH Hepatitis B Research Network's Mass General site Director of the Center for Human Immunology U19 Program Research interests include: HCV interferon resistance mechanisms HIV/HCV coinfection dynamics Lipid metabolism-virus interactions Development of novel antiviral therapies Genetic determinants of treatment response Biomarkers for liver disease progression His lab has developed: High-throughput HCV replicon models Whole genome siRNA screening for host targets Translational studies linking HCV to diabetes and fibrosis Clinical trials of natural compounds like naringenin

Amanda Fortes Franciscoمشاهده پروفایل

استادیار

• Parasitic Diseases
• Drug Discovery
• Trypanosoma Pathogenesis
• +۳ مورد دیگر

Dr. Amanda Fortes Francisco is Assistant Professor in the Department of Infection Biology at the London School of Hygiene & Tropical Medicine. She holds an MSc and PhD in Biological Sciences from the Federal University of Ouro Preto, Brazil, with expertise in parasitic disease pathogenesis and drug discovery. Her research utilizes advanced in vivo imaging systems to study Trypanosoma cruzi and Trypanosoma brucei, focusing on Chagas cardiomyopathy and Environmental Enteric Dysfunction (EED). Her primary research areas include: Chagas disease pathogenesis with focus on inflammation and fibrosis In vivo imaging technology for tracking disease progression High-throughput screening for neglected disease drug discovery Interdisciplinary collaborations to accelerate therapeutic development Dr. Francisco's 15 most recent publications demonstrate consistent focus on therapeutic interventions for trypanosome infections, with emerging themes including: Combination therapies for chronic Chagas disease Novel drug mechanisms targeting topoisomerases and DNA Validation of animal models for pathogenesis studies Application of bioluminescent imaging in efficacy evaluation She serves in multiple institutional roles: Academic Lead for In Vivo Imaging Systems Member of Animal Welfare and Ethical Review Board Member of Flow Cytometry and Imaging Focus Group Member of Genetic Modification Safety Committee Her teaching portfolio includes: Tutor for Distance Learning modules (IDM601, IDM203) Lecturer on Molecular and Cell Biology of Infectious Disease Supervisor of MSc research projects Trainer in animal and histological techniques

Matthew Hirscheyمشاهده پروفایل

دانشیار

• Metabolism
• Mitochondrial Biology
• Cancer Biology
• +۳ مورد دیگر

Matthew Hirschey is an Associate Professor of Medicine, Pharmacology & Cancer Biology, and Cell Biology at Duke University. He is affiliated with the Duke Molecular Physiology Institute, Sarah Stedman Nutrition & Metabolism Center, and Duke Cancer Institute. His research focuses on metabolic control, mitochondrial signaling, and cellular processes in health and disease. Education: Ph.D. from the University of California, Santa Barbara (2006). He has held multiple academic positions at Duke since 2011, progressing from Instructor to current roles as Associate Professor in multiple departments. Research Interests: The Hirschey Lab explores metabolic pathways, mitochondrial signaling, and their roles in cancer, diabetes, and aging. Key areas include protein acylation, NAD+ metabolism, and metabolic reprogramming in tumors. Grants: Recipient of NIH grants including the Endocrinology and Metabolism Training Program (2024–2029) and a project on breast cancer therapy (2024–2028). He mentors students in training programs like the Duke University Program in Environmental Health. Awards: 2013 New Scholar in Aging Award from the Ellison Medical Foundation. Labs/Teams: Leads the Hirschey Lab, collaborating with institutions like Duke-NUS and GenFlow Biosciences. Their work integrates biochemistry, data science, and imaging to uncover metabolic mechanisms.

Chun Liuمشاهده پروفایل

استادیار

• Cardiovascular Diseases
• Stem Cell Biology
• CRISPR Technology
• +۷ مورد دیگر

Dr. Chun Liu is an Assistant Professor in Physiology and Medicine at the Medical College of Wisconsin, affiliated with the Cardiovascular Research Center and Cancer Center. His research focuses on cardiovascular diseases and cancer using induced pluripotent stem cells (iPSCs), CRISPR screening, and multiomics approaches. He completed his PhD in stem cell biology at Peking University and a postdoctoral fellowship at Stanford University, where he developed iPSC-based models for studying diseases like laminopathy cardiomyopathy and drug-induced toxicity. Education: PhD in Stem Cell Biology, Peking University (mentored by Dr. Hongkui Deng) Postdoctoral Fellowship in Cardiovascular Disease, Stanford Cardiovascular Institute (with Dr. Joseph Wu) BS, China Agricultural University Research Interests: Dr. Liu’s lab integrates iPSC-derived disease models with high-throughput CRISPR screens to uncover genetic regulators in heart disease, cardiotoxicity, and cardio-oncology. Key areas include: iPSC reprogramming and differentiation CRISPRi/a screens for drug target discovery Epigenetic mechanisms in vascular dysfunction Population-level disease modeling using iPSCs Publications: Recent work highlights CRISPR-based identification of drug targets for doxorubicin cardiotoxicity, mechanisms of NAA10-linked long QT syndrome, and statin-mediated endothelial protection. These studies emphasize translational applications in precision medicine and drug development. Awards: American Heart Association (AHA) Second Century Early Faculty Independence Award (2023–2026) AHA Career Development Award (2019–2022) Stanford Cardiovascular Institute Seed Grant Advancing Science: Dr. Liu mentors students and researchers in cutting-edge projects like "population-in-a-dish" modeling and CRISPR-Perturb-seq. His lab actively collaborates on stem cell therapies, cardiac organoid engineering, and cardio-oncology drug screening. Open positions exist for postdocs, graduate students, and undergraduates. Labs/Teams: The iPSC-Perturbation Lab focuses on regenerative cardiovascular medicine, leveraging CRISPR tools and iPSCs to address unmet clinical needs in cardiac repair and genetic disease correction.

• Neurology
• Parkinson's Disease
• Biomarkers
• +۳ مورد دیگر

Danielle Feigenbaum, MD is a Clinical Associate Professor (Part-Time) of Neurology at the University of Southern California. Her clinical expertise focuses on movement disorders such as Parkinson’s disease, dystonia, ataxia, and chorea. She actively leads clinical trials for Parkinson’s and dystonia treatments while researching biomarkers for Parkinson’s diagnosis. Her research emphasizes tear-based biomarkers and the role of physical activity in neurological health. Dr. Feigenbaum has contributed to studies on subthalamic nucleus stimulation effects, alpha-synuclein biomarkers, and statin mechanisms in CNS disorders. She has published in journals like Brain Stimul and Biomark Med . Her work bridges clinical practice with translational research, aiming to improve diagnostic tools and treatment strategies for neurodegenerative diseases. No specific awards or grants are listed, but her involvement in multiple clinical trials demonstrates active engagement in therapeutic development.

• Neurogenetics
• Leukodystrophy
• Microglia
• +۸ مورد دیگر

Leslie Sanderson is an Assistant Professor in the Department of Clinical Genetics at Erasmus MC, where she conducts research on rare genetic neurological disorders. Her work integrates molecular genetics, zebrafish models, and cellular biology to understand disease mechanisms and identify potential therapies. Her research focuses on neurogenetic conditions, particularly leukodystrophies, microglial dysfunction, lysosomal storage disorders such as mucopolysaccharidosis, and hereditary spastic paraplegias. She investigates the role of genes involved in membrane trafficking (e.g., VPS16, VPS41, AMFR) and microglial regulation (e.g., CSF1R) in neurodegeneration. The recent articles highlight a strong trend in identifying novel genetic causes of rare diseases and exploring repurposed drug treatments, such as statins. Her studies often involve international collaborations and utilize zebrafish and patient-derived fibroblasts to model disease and test therapeutic interventions. No scientific awards mentioned in the provided text. There is no information available about student advising, grants, or formal mentorship roles in the given text. Her collaborative publications suggest involvement in large research consortia and team-based science, but specific details on grants or leadership roles are not provided. Leslie Sanderson is part of a research team at Erasmus MC focused on clinical genetics and neurodegenerative diseases, likely working within a laboratory environment that uses zebrafish and cellular models to dissect disease mechanisms. She collaborates closely with senior researchers such as Dr. T.J. van Ham and other international experts in genetics and neurology.

Angel Wongمشاهده پروفایل

استادیار

• Pharmacoepidemiology
• Cardiovascular diseases
• Drug safety
• +۳ مورد دیگر

Dr. Angel Wong is an Assistant Professor in the Department of Non-communicable Disease Epidemiology within the Faculty of Epidemiology and Population Health at the London School of Hygiene & Tropical Medicine (LSHTM). She serves as the deputy director of the Centre for Global Chronic Conditions and is actively involved in pharmacoepidemiological research using multinational electronic health records (EHRs) for causal inference studies across diverse healthcare systems in the UK, Hong Kong, Japan, and Denmark. Her educational background includes a BSc in Public Health from the Chinese University of Hong Kong and a PhD in Pharmacoepidemiology from the University of Hong Kong. She joined LSHTM in 2018 as a Research Fellow and was promoted to Assistant Professor in 2020. She also holds honorary positions at the University of Hong Kong as an Honorary Research Associate (since 2019) and Honorary Assistant Professor (since 2023). Dr. Wong's research focuses on applying novel methodologies in health data research to generate real-world evidence. Her work emphasizes using self-controlled designs and propensity scores to minimize confounding and bias, producing high-quality clinical evidence to inform prescribing decisions. Current research projects include investigating drug-drug interactions, safety profiles of cardiovascular and psychotropic medications, and examining how heatwaves alter medication effects using EHRs linked to meteorological data. Her publications demonstrate expertise in self-controlled case series and case-crossover designs, with numerous recent papers focusing on anticoagulant safety and drug interactions. British Heart Foundation grant: "Polypharmacy and the impact of drug interactions with direct oral anticoagulants (DOACs)" (Sep 2019-Feb 2024) MRC grant: "Evaluate and address the impact of COVID-19 restrictions on electronic health records in estimating causal effects" (Jun 2024-May 2026) Hong Kong InnoHK grant: "AI and pharmaceuticals in non-communicable diseases" (Nov 2020-Oct 2025) Dr. Wong is actively involved in professional activities, serving as a journal reviewer for publications like Heart Rhythm, BJGP Open, and Drugs. She has been invited as a keynote speaker at the University of Hong Kong and presented at ISPE's Asian Conference on Pharmacoepidemiology. As an educator, she organizes the Professional Certificate course in Pharmacoepidemiology and Pharmacovigilance at LSHTM and supervises MSc students in Epidemiology, Public Health, and Health Data Science programs.

Maria Victoria Niklison Chirouمشاهده پروفایل

مدرس

• Cancer Metabolism
• Medulloblastoma
• p53-family proteins
• +۷ مورد دیگر

Dr Maria Victoria Niklison Chirou is a Lecturer in Cell and Molecular Biology at the Department of Life Sciences, University of Bath, and a member of the Centre for Therapeutic Innovation. She holds a PhD from Universidad Nacional de Tucumán, Argentina, and has held research positions at the MRC Toxicology Unit and Queen Mary University of London. She joined the University of Bath in 2020 and is actively involved in research on childhood brain tumours, particularly medulloblastoma. Education: Doctor of Philosophy, Universidad Nacional de Tucumán (2009) Master of Biochemistry (2004) Her research focuses on cancer metabolism, particularly how metabolic pathways such as glutamine and lipid metabolism are hijacked in aggressive tumours. She investigates the role of the p53-family proteins in metabolic reprogramming and aims to develop less toxic, targeted therapies for paediatric brain cancers. Her lab explores strategies to starve tumours of essential nutrients to enhance chemotherapy efficacy. The recent publications reflect a strong trend in targeting metabolic vulnerabilities in brain and pancreatic cancers, with a focus on lipid droplets, mevalonate pathway inhibition, and proteasome inhibition. Her work bridges molecular oncology and translational drug discovery. Scientific Awards: BNOS Young Investigator Award (2019) Faculty of Science Recognising Excellence scheme (2024) Nominated for Tutor of the Year (2024) Honorary Lecturer (2020) Dr Niklison Chirou supervises doctoral and master’s students and is accepting new PhD candidates with funding. She leads multiple projects funded by Children's Cancer and Leukaemia Group and The Academy of Medical Sciences. Her public engagement includes school outreach and science communication on repurposed drugs for brain tumours. Lab Members: Philip Ragan (PhD student, 2021–2024) Maria Parikian (MSc student, 2021) Jasmin Kimya Farshchi (ERASMUS visiting student, 2021)

Maria (MariVi) Tejada-Simonمشاهده پروفایل

دانشیار

• Pharmacology
• Neuroscience
• Neurological Disorders
• +۳ مورد دیگر

Maria (MariVi) Tejada-Simon is an Associate Professor of Pharmacology at the University of Houston College of Pharmacy , with joint appointments in Psychology and Biology . She serves as the Director of Faculty Development and focuses on hippocampus-dependent learning, memory, and Fragile X syndrome. B.S. in Biology, Universidad Complutense de Madrid (Spain) M.S., Michigan State University M.Ed., University of Houston Ph.D., Michigan State University Postdoctoral Fellowship, Baylor College of Medicine Her research explores: Hippocampus-dependent learning and memory Cognitive disabilities in Fragile X syndrome Neuronal morphology regulation Mechanisms of seizure induction and death Actin remodeling in neurodevelopmental disorders Drug repurposing for mitochondrial and neurological diseases Her publications highlight advancements in Fragile X syndrome therapies, mitochondrial disease interventions, and educational methodologies in pharmacy and physiology instruction, with a focus on AI integration and cognitive enhancement. Scientific honors include: Fulbright Specialist Program (2025) Outstanding Faculty Leadership Award (2024) Outstanding Advisor Award (2023) Multiple Teaching Excellence Awards (2016-2022) LeJeune International Award Finalist (2010) She has mentored undergraduate research and advised the Hispanic Pharmacy Student Association since 2018, emphasizing faculty development and educational outreach.

• Cardiovascular Clinical Trials
• Diabetes and Vascular Complications
• Epidemiology
• +۷ مورد دیگر

Professor Anthony Keech is a leading academic and clinical researcher at the University of Sydney 's Faculty of Medicine and Health . He serves as Director of Cardiovascular Research at the NHMRC Clinical Trials Centre and holds an NHMRC Senior Principal Research Fellowship. His work focuses on cardiovascular clinical trials , diabetes complications, and trial methodology , with significant contributions to understanding LDL cholesterol reduction , diabetic retinopathy , and biomarker discovery through the FIELD diabetes study and other international trials.

Stephen Cowenمشاهده پروفایل

دانشیار

• Neuroscience
• Cognitive Neuroscience
• Neurodegenerative Diseases
• +۵ مورد دیگر

Stephen Cowen, PhD is an Associate Professor in the Department of Cognition/Neural Systems at the University of Arizona's College of Engineering , where he directs the Decision Making and Learning Laboratory . His research focuses on neural mechanisms underlying cognitive processes, motor behavior, and neurodegenerative disease models. Current faculty member (not former or retired) Active in neuroscience research involving dopamine signaling, theta oscillations, and Parkinson's disease models Research Interests include: Neural oscillations in cognition and movement Dopamine dynamics in reward and disease Neurochemical interventions for Parkinson's dyskinesia Age-related neural changes Sleep's role in memory consolidation Recent Publications highlight: 2025 work on hippocampal theta oscillations and motor behavior Ketamine's therapeutic effects in Parkinson's models Neural correlates of aging and cognitive decline Advanced behavioral analysis systems for rodents Laboratory : The Decision Making and Learning Laboratory develops preclinical models for understanding neural basis of decision-making and motor dysfunction.